Adaptive Biotechnologies is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Our proprietary immune medicine platform reveals and translates the massive genetics of the adaptive immune system with scale, precision and speed to develop products in life sciences research, clinical diagnostics and drug discovery.
Improving the lives of patients by developing proprietary, innovative, and differentiated therapies for the treatment of immuno-inflammatory conditions.
VYNE Therapeutics™ is working to solve some of today’s most difficult therapeutic challenges. Our team has long-standing research and development experience, paired with strong commercial experience. We have a combination of diverse perspectives and industry experience necessary to recognize where conventional approaches fall short, and we are passionate about developing new and unexpected solutions to improving patient care.